You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

filgrastim

Showing 26 - 50 of 687
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease Trial in Los Angeles (drug, procedure, biological)

Recruiting
  • Crohn Disease
  • Los Angeles, California
    Cedars-Sinai Medical Center
Mar 23, 2022

Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)

Recruiting
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

AIDS Related Lymphoma, AIDS-Associated Lymphoma Trial run by the NCI (Filgrastim, Rituximab, EPOCH)

Completed
  • AIDS Related Lymphoma
  • AIDS-Associated Lymphoma
  • Filgrastim
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jan 18, 2022

Critical Limb Ischemia Trial in Chicago (Pneumatic calf compression, Filgrastim)

Completed
  • Critical Limb Ischemia
  • Pneumatic calf compression
  • Filgrastim
  • Chicago, Illinois
    University of Illinois at Chicago
Nov 10, 2021

Breast Cancer Trial in Duarte (biological, drug, procedure)

Active, not recruiting
Has Results
  • Breast Cancer
  • filgrastim
  • +10 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Feb 17, 2022

Glioblastoma Multiforme, Glioblastoma Multiforme, Adult, Supratentorial Glioblastoma Trial in Bethesda, Cleveland (biological,

Not yet recruiting
  • Glioblastoma Multiforme
  • +3 more
  • P140K-MGMT
  • +5 more
  • Bethesda, Maryland
  • +1 more
Jul 4, 2022

Prostate Cancer Trial in United States (Docetaxel-PNP, Ribociclib, Prednisone)

Completed
Has Results
  • Prostate Cancer
  • San Francisco, California
  • +5 more
Aug 9, 2022

Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate

Recruiting
  • Aggressive Non-Hodgkin Lymphoma
  • +8 more
  • Polatuzumab Vedotin
  • +6 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 26, 2023

Neuroendocrine Tumors, Tumors, Cancer Trial in Madison (TAS-102, Temozolomide, Filgrastim)

Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Oct 29, 2021

Breast Cancer Trial in Duarte (biological, drug, procedure)

Active, not recruiting
  • Breast Cancer
  • filgrastim
  • +5 more
  • Duarte, California
    Cancer Center and Beckman Research Institute, City of Hope
Feb 17, 2022

Fanconi Anemia Trial in Minneapolis (anti-thymocyte globulin, filgrastim, busulfan)

Completed
Has Results
  • Fanconi Anemia
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Nov 4, 2021

Hematologic Malignancy Trial in New York (melphalan, fludarabine, thiotepa)

Active, not recruiting
  • Hematologic Malignancy
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)

Completed
  • Childhood Solid Tumors
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Feb 8, 2021

Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (drug, biological, other)

Completed
  • Recurrent Adult Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
  • Houston, Texas
    M D Anderson Cancer Center
Jun 18, 2021

Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia, Refractory B Acute Lymphoblastic Leukemia Trial in

Terminated
Has Results
  • Philadelphia Chromosome Negative
  • +2 more
  • Blinatumomab
  • +11 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 3, 2022

Leukemia Trial (biological, drug, procedure, radiation)

Active, not recruiting
  • Leukemia
  • aldesleukin
  • +9 more
  • (no location specified)
Feb 17, 2022

Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)

Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 26, 2022

HIV Trial in Chapel Hill, Durham (Nelfinavir mesylate, Lamivudine, Filgrastim)

Completed
  • HIV Infections
  • Nelfinavir mesylate
  • +4 more
  • Chapel Hill, North Carolina
  • +1 more
Oct 27, 2021

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia With

Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +5 more
  • Blinatumomab
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 1, 2022

Fanconi Anemia Trial in Minneapolis (biological, drug, procedure)

Completed
Has Results
  • Fanconi Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Oct 8, 2021

Acute Leukemia, MDS, T-lymphoblastic Lymphoma Trial (drug, radiation, procedure)

Not yet recruiting
  • Acute Leukemia
  • +6 more
  • (no location specified)
Dec 8, 2021

Sarcoma Trial in New York (biological, drug, procedure, radiation)

Active, not recruiting
  • Sarcoma
  • filgrastim
  • +10 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Nov 5, 2021

AIDS-Related Burkitt Lymphoma, AIDS-Related Diffuse Large B-cell Lymphoma, AIDS-Related Plasmablastic Lymphoma Trial run by the

Active, not recruiting
  • AIDS-Related Burkitt Lymphoma
  • +5 more
  • Bethesda, Maryland
    NCI Lymphoid Malignancies Branch
Jul 31, 2022

Breast Cancer, Neutropenia, Febrile Neutropenia Trial in Seoul (Filgrastim, Peg-filgrastim)

Terminated
  • Breast Cancer
  • +2 more
  • Seoul, Korea, Republic of
    Asan Medical Center
Jul 29, 2020

Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

Recruiting
  • Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 20, 2022